All About Multiple Sclerosis

Multiple Sclerosis News for March 2004

31st March 2004:       Antegren in Europe

31st March 2004:       Update on Goats Serum

31st March 2004:       Oral Cladribine for MS Trial Results

31st March 2004:       High-Dose Cyclophosphomide for MS

31st March 2004:       Study Finds IFN-beta Slows Brain Atrophy

31st March 2004:       MS Scientists Criticise Autoimmunity Theory

31st March 2004:       Searching for Clues Into MS

31st March 2004:       Review of Interferons in RRMS

31st March 2004:       Review of Hyperbaric Oxygen Therapy for MS

31st March 2004:       Review of Methotrexate for MS

31st March 2004:       Review of Occupational Therapy for MS

31st March 2004:       Oral Fumarate for MS

31st March 2004:       MS Risk Gradient in Ireland

31st March 2004:       Adult MS Diagnostic Criteria Not Good for Kids

31st March 2004:       Child Death Stress Linked to MS

31st March 2004:       Gene Regulates Nerve Insulation

31st March 2004:       Tissue Banking and Biological Modelling

31st March 2004:       Low-Dose Naltrexone

31st March 2004:       Female Viagra?

31st March 2004:       Some Pharma MS Events

31st March 2004:       US Funds Swedish Stem Cell Research

31st March 2004:       Germans Back Adult Stem Cells

31st March 2004:       Canada Passes Cloning Law

31st March 2004:       New MS Information Centre Opens

31st March 2004:       Germany Debates Gene Patents

31st March 2004:       Disenchantment with NMSS Local Chapter

31st March 2004:       Assisted Devices for PwMS

31st March 2004:       Six Year Old w/MS

31st March 2004:       Award for MS World Founder

31st March 2004:       Baring All for MS

27th March 2004:       Medline: Pathology of Newly Forming Lesion in RRMS

27th March 2004:       Medline: Lipoatrophy Associated with Copaxone in MS

27th March 2004:       Medline: Attempting to Improve on Copaxone

27th March 2004:       Medline: Sativex - a Novel Pain Killer Made From Cannabis

27th March 2004:       Medline: Case Study of IFN Therapy in a Child w/MS

27th March 2004:       Medline: Significance of Antibodies to IFNb Treatment of MS

27th March 2004:       Medline: Evaluating Grimaldi's Method as MS Therapy

27th March 2004:       Medline: Axonal Loss in Multiple Sclerosis

27th March 2004:       Medline: Evidence for Early Gray Matter Involvement in RRMS

27th March 2004:       Medline: Brain Atrophy in PwMS with APOE-e4 Gene

27th March 2004:       Medline: Cervical Spinal Cord Lesions and Disability in MS

27th March 2004:       Medline: Acute Aphasia in Multiple Sclerosis

27th March 2004:       Medline: Does Optimism Affect Symptoms in Chronic Disease

27th March 2004:       Medline: Coping and Psychological Adjustment in PwMS

27th March 2004:       Medline: History Mechanisms and Treatment of MS in Europe

27th March 2004:       Medline: Analysing Quality of Life Measures in MS

27th March 2004:       Medline: Evaluating INTERMED as Measure in MS

27th March 2004:       Medline: T Cell Recognition in CNS Autoimmunity

27th March 2004:       Medline: CYFIP2 is Abundant in TCells of PwMS

27th March 2004:       Medline: Anti-MOG Autoantibodies in PwMS

27th March 2004:       Medline: Examining Neuropathology of MS with MRI

27th March 2004:       Medline: Bax Gene Makes EAE Worse

27th March 2004:       Medline: New EAE Model that Predicts Effects of Lesions

27th March 2004:       Medline: Rat Microglial Cells and Cannabinoids

27th March 2004:       Medline: Fatigue in Neurological Disorders

27th March 2004:       Medline: Neuroradiological Features of Vertigo

27th March 2004:       Medline: Low Frequency Hearing Loss

27th March 2004:       Medline: Targetting T Cell Population to Prevent Autoimmunity

27th March 2004:       Medline: Cetirizine and Allopurinol Against Autoimmune Disorders

27th March 2004:       Medline: Chemokine Inhibition

27th March 2004:       Medline: Quasi-Linkage: a Confounding Factor in Genetics of Complex Diseases

27th March 2004:       Medline: Study of Antibodies to Bacterial Superantigens

27th March 2004:       Medline: New Cytokine Testing Technique

21st March 2004:       New Research Funded by NMSS

21st March 2004:       Current Research Projects Funded by NMSS

21st March 2004:       Full Text: Oligodendrocyte Death Precedes Inflammation in MS

21st March 2004:       Full Text: Stress and MS Relapses

21st March 2004:       Full Text: Response to Stress and MS Article

21st March 2004:       Full Text: Optimising Long-Term MS Treatment

21st March 2004:       Full Text: Role for Statins in Immunomodulation

20th March 2004:       Medline: Epstein Barr Virus Infection in MS

20th March 2004:       Medline: Brain Tissue Loss Continues After ASCT in PwMS

20th March 2004:       Medline: Stress and MS Relapses

20th March 2004:       Medline: Aggressive MS and Mitoxantrone

20th March 2004:       Medline: Therapeutic Use of Cannabis

20th March 2004:       Medline: Can MS be Diagnosed from 1st Relapse?

20th March 2004:       Medline: Whether to Treat 1st Demyelinating Episode?

20th March 2004:       Medline: Growth Factors, Stem Cells, Oligodendrocytes and Remyelination

20th March 2004:       Medline: Platelet Derived Growth Factor and Oligodendrocyte Progenitors

20th March 2004:       Medline: Study of Sixth Nerve Palsy

20th March 2004:       Medline: Neuropathic Pain

20th March 2004:       Medline: Latitudinal Variation in MS Prevalence in Ireland

20th March 2004:       Medline: Neuroretinitis in PwMS

20th March 2004:       Medline: Neurological Disorders in Pregnancy

20th March 2004:       Medline: Multiple Sclerosis Trait

20th March 2004:       Medline: Microorganisms and Autoimmunity

20th March 2004:       Medline: MS Symptom and Impact Diary

20th March 2004:       Medline: MRI Study of Early Onset MS

20th March 2004:       Medline: MRI Study of Water in CNS of PwMS

20th March 2004:       Medline: CSF Chemokine Levels in Devic's and MS

20th March 2004:       Medline: Regulatory T Cells, MS and MS Drugs

20th March 2004:       Medline: Episodic Disseminated Inflammation of CNS

20th March 2004:       Medline: TRAIL Promoter in MS

20th March 2004:       Medline: Molecular Transport Across BBB in CNS Inflammation

20th March 2004:       Medline: T Cell Activation and Disease Activity at MS Onset

20th March 2004:       Medline: Cyclooxygenase-2 in MS Lesions

20th March 2004:       Medline: Retinal Antigens Recognized by Serum Antibodies of PwMS

20th March 2004:       Medline: NOS and Enzyme Activity in MS

20th March 2004:       Medline: Kallikrein 6 and CNS Inflammatory Disease

20th March 2004:       Medline: Estriol Ameliorates Disease in Male Mice with EAE

20th March 2004:       Medline: Novel Protective Model Against EAE

20th March 2004:       Medline: RTL401 Ameliorates EAE

20th March 2004:       Medline: Targetting CC Chemokine in MS Animal Model

20th March 2004:       Medline: Induction of EAE in Rat Breed

20th March 2004:       Medline: Estrogen - A Double Edged Sword

20th March 2004:       Medline: Fas Ligand and Cell Death in CNS Degenerative Disorders

20th March 2004:       Medline: Neurodegenerative Disorders

20th March 2004:       Medline: Real and Presumed Side-Effects of Vaccination

20th March 2004:       Medline: Wellness for Women with Chronic Disabling Conditions

20th March 2004:       Medline: Measuring Occupational Performance

18th March 2004:       Job Stress May Exacerbate MS

18th March 2004:       Vaccine Patch Linked to Diabetes and MS

18th March 2004:       Agent Helps Nerves Grow in Damaged Spinal Cords

18th March 2004:       Treatment Could Help Paralysis

18th March 2004:       Nerve Cell Proteins May Reduce Disability

18th March 2004:       Swallowing Therapy

18th March 2004:       More on Vitamin D Deficiency

18th March 2004:       Making Sense of Basic Research Studies in MS

18th March 2004:       Microscopy Shows that T Cell Contact Kills Neurons

18th March 2004:       Measuring Brain Atrophy without MRI

18th March 2004:       Drug Guidance to MS Nurses

18th March 2004:       Gray Matter Atrophy Seen Early in MS

18th March 2004:       Protective Protein against Neurodegenerative Disorders

18th March 2004:       Treating MS Spasms

18th March 2004:       Disease Be Not Proud

18th March 2004:       Botox Uses Go Past Skin Deep

18th March 2004:       Novel Oral RA and MS Therapeutics

18th March 2004:       Nautilus Biotech Progress on Improved IFNb for MS

18th March 2004:       Clues to MJ Effects

18th March 2004:       Ginkgo for MS

18th March 2004:       Science Backs Tai Chi Benefits

18th March 2004:       Senate Committee Backs Stem Cell Research

18th March 2004:       US Lawmakers Want to Ease Stem Cell Restrictions

18th March 2004:       UK Centre of Excellence for Clinical Imaging

18th March 2004:       Seattle Clinic a Hub for MS Care

18th March 2004:       $12.4m For New MS Investigations

18th March 2004:       MS Frontiers

18th March 2004:       MS Group Faces Closure

18th March 2004:       MS Awareness Month

18th March 2004:       NMSS Collaborative MS Research Center Awards

18th March 2004:       Welsh Brain Cemtre

18th March 2004:       UK £76m Imaging Research Centre

18th March 2004:       Ireland Anger over Rehab Facilities

18th March 2004:       AVS Joins Fight Against MS

18th March 2004:       Disabled Driver Fights Parking Ticket

18th March 2004:       More on Disabled Parking Ticket Controversy

18th March 2004:       Yet More on Disabled Parking Tickets

18th March 2004:       British Columbia Marijuana Party

18th March 2004:       California Med MJ Activists Converge

18th March 2004:       Opinion on Med MJ in New York City - Yes

18th March 2004:       Opinion on Med MJ in New York City - No

18th March 2004:       Connecticut - Med MJ Bill

18th March 2004:       Intimacy and Sexuality with MS

18th March 2004:       Disabled Needs Meeting

18th March 2004:       Interview with Various People on MS

18th March 2004:       Norman P Haverkos

18th March 2004:       Louie Unser

18th March 2004:       More on Louie Unser

18th March 2004:       Life After MS

18th March 2004:       Inspirational Singer w/MS

18th March 2004:       More on Blindsided

18th March 2004:       Gray Matters

18th March 2004:       Firefighters Save Woman w/MS

18th March 2004:       Triathlete w/MS

18th March 2004:       Role Model for Living with MS

18th March 2004:       Boston Cure Project Scavenger Hunt

18th March 2004:       Biker Working to Raise Money for MS

18th March 2004:       Legoland MS Fundraiser

18th March 2004:       Daffodil High Tea Fund Raiser

11th March 2004:       Medline: IVIg and MRI in MS

11th March 2004:       Medline: IFNb-1b Slows Atrophy in RRMS

11th March 2004:       Medline: Effect of IFNb-1a on MMP-9 and TIMP-1 in RRMS

11th March 2004:       Medline: Steroid Effects on Glial Cells

11th March 2004:       Medline: PPARg Therapy

11th March 2004:       Medline: Therapeutic Potential of Botox

11th March 2004:       Medline: Minocycline Reduces Oligodendrocyte Death in SCI

11th March 2004:       Medline: DNA Vaccines for Autoimmune Diseases

11th March 2004:       Medline: Testosterone Increases Damage to Oligodendrocytes

11th March 2004:       Medline: Risk of MS in Bereaved Parents

11th March 2004:       Medline: APOE Genes Linked to MS Severity in Women Only

11th March 2004:       Medline: HFEC-282Y Gene and MS

11th March 2004:       Medline: TNF-376A Gene Marks Susceptibility to MS

11th March 2004:       Medline: Assessing Fatigue in MS

11th March 2004:       Medline: Effects of IFNg and TNFa on Oligodendrocyte Progenitor Cells

11th March 2004:       Medline: Oxidative Stress and MS

11th March 2004:       Medline: Meta-Memory in MS

11th March 2004:       Medline: Clinical Callosum Syndrome in MS

11th March 2004:       Medline: Evaluation of MRI Criteria for MS in Children

11th March 2004:       Medline: fMRI Study of PwMS Doing Cognitive Tasks

11th March 2004:       Medline: fMRI Study of Object Manipulation by PwMS

11th March 2004:       Medline: MRI Study of Myelin Water Fraction in MS

11th March 2004:       Medline: Segmentation of White Matter Lesions under MRI

11th March 2004:       Medline: Prinzmetal Variant Angina Associated with MS

11th March 2004:       Medline: Mycobacteria and Autoimmune Diseases

11th March 2004:       Medline: Astrocytic Beta2 Adrenergic Receptors and MS

11th March 2004:       Medline: T Cells, Neurons and Photon Microscopy

11th March 2004:       Medline: Monophasic, Solitary, Tumefactive, Demyelinating Lesions

11th March 2004:       Medline: Estrogen Receptors and Caveolin-1 in Oligodendrocytes

11th March 2004:       Medline: FGF2 in Rat OPCs Promotes Remyelination

11th March 2004:       Medline: Oxidation of Oligodendrocyte Progenitors in Rats

11th March 2004:       Medline: Protective Effects of Astrocytes in SCI

11th March 2004:       Medline: Autoimmune Diseases in a Nigerian Woman

9th March 2004:         Faulty Immune System May Not Be Cause of MS

8th March 2004:         Medline: Role for Statins in Immunomodulation

8th March 2004:         Medline: Trial of Resiniferatoxin for Incontinence

8th March 2004:         Medline: Sex Steroid Regulation of Microglial Cell Activation in MS

8th March 2004:         Medline: Ablative Immunotherapy for Autoimmune Diseases

8th March 2004:         Medline: Treatment Optimization for PwMS

8th March 2004:         Medline: Effects of Interferon-Beta on Microglial Functions

8th March 2004:         Medline: Geography and MS in Cuba

8th March 2004:         Medline: Focus Groups for PwMS

8th March 2004:         Medline: HLA Genes and MS Susceptibilty

8th March 2004:         Medline: Unique Gene Expression During MS Activity

8th March 2004:         Medline: Synapsin III Gene Promoter and MS

8th March 2004:         Medline: Vitreoretinal Traction Syndrome and MS

8th March 2004:         Medline: Features of Devic's Disease

8th March 2004:         Medline: Early Development of MS Associated with Grey Matter Atrophy

8th March 2004:         Medline: Ventricular Diameters in MS

8th March 2004:         Medline: MHC on Different Cells in MS Lesions

8th March 2004:         Medline: Myelin-Specific Helper T Cells in MS

8th March 2004:         Medline: Summary of New MS Diagnostic Criteria

8th March 2004:         Medline: Neuronal Excitability with Transcranial Magnetic Stimulation in RRMS

8th March 2004:         Medline: MBP-Reactive T Cells and MS

8th March 2004:         Medline: Neuronal Antigens Modulate Immune Response in EAE

8th March 2004:         Medline: Gene Therapy for EAE

8th March 2004:         Medline: Fc Receptors and Gamma-Chain in EAE

8th March 2004:         Medline: Chemokine Expression in EAE

8th March 2004:         Medline: Experiments with MOG in EAE

8th March 2004:         Medline: T Cell Receptor NTB-A Regulates Autoimmune Disease

8th March 2004:         Medline: Inhibiting IL-12

8th March 2004:         Medline: IL-17: a Mediator of Inflammatory Responses

8th March 2004:         Medline: Calpain Inhibition

5th March 2004:         T Cell Vaccination Fails in Trial

5th March 2004:         Stress of Losing Child Increases MS Risk

5th March 2004:         Scientists Rregrow Optic Nerves

5th March 2004:         MS Society Research Bulletin #31

5th March 2004:         Replacing the Immune System in MS

5th March 2004:         Taming MS

5th March 2004:         MS in Ulster Linked to Scottish Settlers

5th March 2004:         High Rates of MS in Donegal Ireland

5th March 2004:         Investigational Treatment for Uveitis

5th March 2004:         Even More on Vitamin D

5th March 2004:         Is Myelin the Culprit in MS?

5th March 2004:         MS Animal Experiments Delayed Medical Progress

5th March 2004:         MS Doesn't Always Progress

5th March 2004:         More on Antegren

5th March 2004:         Harvard Stem Cell Research Center

5th March 2004:         National MS Education and Awareness Month

5th March 2004:         Disability Awareness Month in Indiana

5th March 2004:         Let Medicines Pay for Research

5th March 2004:         Dangers of Druggists' Customized Brews

5th March 2004:         Donors Dig Deep for Minibus

5th March 2004:         US Bill Banning Mercury Fillings Fails

5th March 2004:         Cameras Can Catch Disabled Parking Violators

5th March 2004:         Med MJ in Texas

5th March 2004:         Support Group Helps People Cope

5th March 2004:         Life Planning and Independence

5th March 2004:         Quicker Diagnosis for MS

5th March 2004:         Woman w/MS

5th March 2004:         New Wheelchair for Woman w/MS

5th March 2004:         Another Stolen Wheelchair and a Football Club

5th March 2004:         More on Stuart Falk's Van

5th March 2004:         Basketball Coach w/MS Steps Down

5th March 2004:         Woman Behind Cure MS Now!

5th March 2004:         Marathon Runner w/MS

5th March 2004:         MSAA Volunteer w/MS

5th March 2004:         More on Paul Novoselick

5th March 2004:         Scottish Politician's Wife w/MS

5th March 2004:         Competition for MS Research

2nd March 2004:         Medline: ASCT and Immunosuppression for MS

2nd March 2004:         Medline: Case Study: Heart Failure with Mitoxantrone for MS

2nd March 2004:         Medline: Liver Injury Associated with IFNb for MS

2nd March 2004:         Medline: Review of Interferons in RRMS

2nd March 2004:         Medline: Prospects for Neuroprotection in MS

2nd March 2004:         Medline: Neurodegeneration and Neuroprotection in MS

2nd March 2004:         Medline: IFNg Receptor Levels in MS Normalized by IFNb

2nd March 2004:         Medline: Second International Conference on MS

2nd March 2004:         Medline: 19th ECTRIMS Congress

2nd March 2004:         Medline: Disability Profile of MS Over 10 Years

2nd March 2004:         Medline: Disability in Elderly PwMS

2nd March 2004:         Medline: Human Herpes Virus-6 Infection

2nd March 2004:         Medline: Depression and Brain Abnormalities in MS

2nd March 2004:         Medline: Neuronal Cell Injury Precedes Brain Atrophy in MS

2nd March 2004:         Medline: EBV-Transformed B cells in PwMS

2nd March 2004:         Medline: B Cell Immunity in MS

2nd March 2004:         Medline: T Cell Receptor Repertoire in PwMS

2nd March 2004:         Medline: T Cell Receptor Beta Chain Transcriptome in MS

2nd March 2004:         Medline: Brain Infiltrating Killer T Cells Persist in PwMS

2nd March 2004:         Medline: Studying Immune Cells in PwMS

2nd March 2004:         Medline: Brain MR Post-Gadolinium Contrast in MS

2nd March 2004:         Medline: Magnetic Resonance Imaging Guidelines

2nd March 2004:         Medline: Epidemiology of Fecal Incontinence

2nd March 2004:         Medline: Quality of Life and Economic Cost of MS

2nd March 2004:         Medline: Evaluating Cognitive Function in MS

2nd March 2004:         Medline: Improving Evaluation of Therapy in MS

2nd March 2004:         Medline: Endothelial Microparticles as Markers of BBB Dysfunction

2nd March 2004:         Medline: Differences between Mouse and Human Immunology

2nd March 2004:         Medline: Autoantigen Expressing B Cells Protect Against EAE

2nd March 2004:         Medline: EAE, Tolerance, Molecular Mimicry and Milk Protein

2nd March 2004:         Medline: Chemokines and Chemokine Receptors in EAE

2nd March 2004:         Medline: Disappearing T1 Black Holes in TMEV

2nd March 2004:         Medline: MRI Lesion Development in TMEV

2nd March 2004:         Medline: Autoreactive CD4+ T Cells in EAE

2nd March 2004:         Medline: Muscle Changes After EAE

2nd March 2004:         Medline: Medical Inadmissability in Canadian Immigration

Back